Suvanza (SUVZ) Price & Analysis

6 Followers

SUVZ Stock Chart & Stats

$0.05

$0.00(0.00%)

At close: Apr 23 4:00 PM EDT

$0.05

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.05 - $0.05

Previous CloseN/A

Volume10.00

Average Volume (3M)0.00

Market Cap

$2.65K

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.46

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding13,259,332

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.00

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SUVZ FAQ

What was Suvanza’s price range in the past 12 months?

Suvanza lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.

What is Suvanza’s market cap?

Suvanza’s market cap is $2.65K.

When is Suvanza’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Suvanza’s earnings last quarter?

Currently, no data Available

Is Suvanza overvalued?

According to Wall Street analysts Suvanza’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Suvanza pay dividends?

Suvanza does not currently pay dividends.

What is Suvanza’s EPS estimate?

Suvanza’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Suvanza have?

Suvanza has 13,259,332 shares outstanding.

What happened to Suvanza’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Suvanza?

Currently, no hedge funds are holding shares in SUVZ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Suvanza

Suvanza Pharma, LLC is an emerging biotechnology enterprise dedicated to developing RapiDerm, an innovative drug delivery system applied to the skin, specifically targeting dermatological disorders. The company, which began operations in 2004 and is headquartered in Miami Beach, Florida, officially changed its name from Hamilton PNG to Suvanza Pharma, LLC in March 2010.